"Drug Xeloda Prolongs Survival For Some Breast Cancer Patients" - Amy Norton
A drug called Xeloda can extend the lives of women whose breast cancer is not wiped out by standard treatment, a new clinical trial finds. Stephen Malamud, MD, associate professor of medical oncology at the Icahn School of Medicine at Mount Sinai said "Xeloda is a pill, so it's easy to take and is much less toxic than standard chemotherapy, most importantly, it extended overall survival in this study."
- Stephen Malamud, MD, Associate Professor, Medicine, Hematology, Medical Oncology, Icahn School of Medicine at Mount Sinai
Learn more
Additional Coverage:
HealthDay
WREX
Mount Sinai’s Alison Snow, PhD, MSW, Named 2026 Oncology Social Worker of the Year
Mar 24, 2026 View All Press Releases
Mount Sinai Study May Help Cancer Patients Keep Their Bladder
Feb 19, 2026 View All Press Releases
